lexapro Drug Patent Profile
✉ Email this page to a colleague
When do Lexapro patents expire, and what generic alternatives are available?
Lexapro is a drug marketed by Abbvie and is included in two NDAs.
The generic ingredient in LEXAPRO is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lexapro
A generic version of lexapro was approved as escitalopram oxalate by AMNEAL PHARMS on March 14th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for lexapro?
- What are the global sales for lexapro?
- What is Average Wholesale Price for lexapro?
Summary for lexapro
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 161 |
Patent Applications: | 655 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for lexapro |
Drug Sales Revenues: | Drug sales revenues for lexapro |
What excipients (inactive ingredients) are in lexapro? | lexapro excipients list |
DailyMed Link: | lexapro at DailyMed |
Recent Clinical Trials for lexapro
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2/Phase 3 |
National Center for Complementary and Integrative Health (NCCIH) | Phase 2/Phase 3 |
University of Michigan | Phase 2/Phase 3 |
Pharmacology for lexapro
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Paragraph IV (Patent) Challenges for LEXAPRO
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LEXAPRO | Capsules | escitalopram oxalate | 5 mg | 021323 | 1 | 2005-08-17 |
LEXAPRO | Capsules | escitalopram oxalate | 10 mg and 20 mg | 021323 | 1 | 2005-03-30 |
US Patents and Regulatory Information for lexapro
lexapro is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting lexapro
NEW PATIENT POPULATION
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | LEXAPRO | escitalopram oxalate | SOLUTION;ORAL | 021365-001 | Nov 27, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lexapro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | LEXAPRO | escitalopram oxalate | SOLUTION;ORAL | 021365-001 | Nov 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for lexapro
See the table below for patents covering lexapro around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 170280 | ⤷ Sign Up | |
Portugal | 1414435 | ⤷ Sign Up | |
Japan | 5192568 | ⤷ Sign Up | |
Peru | 20030304 | COMPOSICION CRISTALINA QUE CONTIENE ESCITALOPRAM | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for lexapro
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0347066 | SZ 42/2002 | Austria | ⤷ Sign Up | |
0347066 | 2002C/039 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESCITALOPRAM. OXALAT. (INN) ESCITALOPRAM; NATL. REGISTRATION NO/DATE: 7004 IE10 F 3 20020729; FIRST REGISTRATION: SE 17084 20011207 |
0347066 | 90999 | Luxembourg | ⤷ Sign Up | |
0347066 | SPC/GB02/049 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ESCITALOPRAM OXALATE; REGISTERED: SE 17084/85/86/87 20011207; UK PL 13761/0008 20020610; UK PC 13761/0009 20020610; UK PL 13761/0010 20020610; UK PL 13761/0011 20020610; UK PL 13761/0012 20020610; UK PL 13761/0013 20020610; UK PL 13761/00014 20020610; UK PL 13761/0015 20020610 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |